The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4

Journal of Virology

Volumn 69, Issue 11, 1995, Pages 6904-6910

  Benkirane, Monsef ^a,e   Schmid Antomarchi, Heidy ^b   Littman, Dan R ^c   Hirn, Michel ^d   Rossi, Bernard ^b   Devaux, Christian ^a,b  

^a CNRS   (France)

^b INSERM   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Immunotech   (France)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL RECEPTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0028883789     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.69.11.6904-6910.1995     Document Type: Article

References (40)

1. Arthos, J., K. C. Deen, M. A. Chaikin, J. A. Fornwald, G. Sathe, Q. J. Sattentau, P. R. Clapham, R. A. Weiss, J. S. McDougal, C. Pietropaolo, R. Axel, A. Truneh, P. J. Maddon, and R. W. Sweet. 1989. Identification of the residues in human CD4 critical for the binding of HIV. Cell 57:469-481.
2. Bedinger, P., A. Moriarty, R. C. von Borstel II, N. J. Donovan, K. S. Steimer, and D. R. Littman. 1988. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature (London) 334:162-165.
3. Benkirane, M., D. Blanc-Zouaoui, M. Hirn, and C. Devaux. 1994. Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells. J. Virol. 68:6332-6339.
4. Benkirane, M., P. Corbeau, V. Housset, and C. Devaux. 1993. An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO J. 12:4909-4921.
5. Benkirane, M., M. Hirn, D. Carrière, and C. Devaux. 1995. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J. Virol. 69:6898-6903.
6. Benkirane, M., K.-T. Jeang, and C. Devaux. 1994. The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO J. 13:5559-5569.
7. Chirmule, N., V. S. Kalyanaraman, and S. Pawha. 1994. Signal transduced through the CD4 molecule on T lymphocytes activate NF-κB. Biochem. Biophys. Res. Commun. 203:498-505.
8. Corbeau, P., M. Benkirane, R. Weil, C. David, S. Emiliani, D. Olive, C. Mawas, A. Serre, and C. Devaux. 1993. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not viral entry. J. Immunol. 150:290-301.
9. Corbeau, P., C. Devaux, F. Kourilsky, and J. C. Chermann. 1990. An early postinfection signal mediated by monoclonal anti-β2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in activated peripheral blood mononuclear cells. J. Virol. 64:1459-1464.
10. Dent, P., W. Haser, T. A. J. Haystead, L. A. Vincent, T. M. Roberts, and T. W. Sturgill. 1992. Activation of mitogen-activated protein kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404-1406.
11. Ettehadieh, E., J. S. Sanghera, S. L. Pelech, D. Hess-Bienz, J. Watts, N. Shastri, and R. Aebersold. 1992. Tyrosyl phosphorylation and activation of MAP kinases by p56lck. Science 255:853-855.
12. Fields, A. P., D. P. Bednarik, A. Hess, and W. S. May. 1988. Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature (London) 333:278-280.
13. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
14. Golding, H., R. Blumenthal, J. Manischewitz, D. R. Littman, and D. S. Dimitrov. 1993. Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time. J. Virol. 67:6469-6475.
15. Gulbins, E., K. M. Coggeshall, G. Baier, S. Katzav, P. Burn, and A. Altman. 1993. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science 260:822-825.
16. Gupta, S., A. Weiss, G. Kumar, S. Wang, and A. Nel. 1994. The T-cell antigen receptor utilizes lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. J. Biol. Chem. 269:17349-17357.
17. Haffar, O. K., P. A. Moran, M. D. Smithgall, M. L. Diegel, P. Sridhar, J. A. Ledbetter, J. M. Zarling, and S. L. Hu. 1992. Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles. J. Virol. 66:4279-4287.
18. lck in human CD4 T lymphocytes. Eur. J. Immunol. 23:600-607.
19. + T cells inhibits the binding activity of NF-AT, NF-κB, and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur. J. Immunol. 24:2646-2652.
20. lck with CD4 in human T lymphocytes. J. Biol. Chem. 266:11176-11183.
21. Kornfeld, H., W. W. Cruikshank, S. E. Pyle, J. S. Berman, and D. M. Center. 1988. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature (London) 335:445-148.
22. Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature (London) 358:417-421.
23. Maddon, P. J., J. S. McDougal, P. R. Clapham, A. G. Dalgleish, S. Jamal, R. A. Weiss, and R. Axel. 1988. HIV infection does not require endocytosis of its receptor, CD4. Cell 54:865-874.
24. Nel, A. E., S. Pollack, G. Landreth, J. A. Ledbetter, L. Hultin, K. Williams, R. Katz, and B. Akerley. 1990. CD3 mediated activation of MAP-2 kinase can be modified by ligand of the CD4 receptor: evidence for tyrosine phosphorylation during activation of this kinase. J. Immunol. 145:971-979.
25. Pautrat, G., M. Suzan, D. Salaun, P. Corbeau, C. Allasia, G. Morel, and P. Filippi. 1990. Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. Virology 179:749-758.
26. Pollack, S., J. A. Ledbetter, R. Katz, K. Williams, B. Akerley, K. Franklin, G. Schieven, and A. E. Nel. 1991. Evidence for involvement of glycoprotein-CD45 phosphatase in reversing glycoprotein-CD3-induced microtubule-associated protein 2 kinase activity in Jurkat T cells. Biochem. J. 276:481-485.
27. Poulin, L., L. A. Evans, S. Tang, A. Barboza, H. Legg, D. R. Littman, and J. A. Levy. 1991. Several CD4 domains can play a role in human immunodeficiency virus infection of cells. J. Virol. 65:4893-4901.
28. Roberts, T. M. 1992. A signal chain events. Nature (London) 360:534-535.
29. Rudd, C. E., J. M. Trevillyan, J. D. Dasgupta, L. L. Wong, and S. F. Schlossman. 1988. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase from human T lymphocytes. Proc. Natl. Acad. Sci. USA 85:5190-5194.
30. Ryu, S. E., P. D. Kwong, A. Truneh, T. G. Porter, J. Arthos, M. Rosenberg, X. Dai, N. H. Xuong, R. Axel, R. W. Sweet, and W. A. Hendrickson. 1990. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (London) 348:419-426.
31. Sattentau, Q., and R. A. Weiss. 1988. The CD4 antigen: physiological ligand and HIV receptor. Cell 52:631-633.
32. Schmid-Antomarchi, H. Unpublished data.
33. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
34. Stevenson, M., S. Haggerty, C. A. Lamonica, C. M. Meir, S. K. Welch, and A. J. Wasiak. 1990. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J. Virol. 64:2421-2425.
35. Tong-Starksen, S. E., P. A. Luciw, and M. Peterlin. 1989. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J. Immunol. 142:702-707.
36. lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J. 13:774-783.
37. Wang, J., Y. Yan, T. P. J. Garrett, J. Liu, D. W. Rodgers, R. L. Garlick, G. E. Tarr, Y. Husain, E. L. Reinherz, and S. C. Harrison. 1990. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (London) 348:411-418.
38. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
39. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Y. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717-1725.
40. lck association. J. Exp. Med. 179:1973-1983.